ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tan, M
Right arrow Articles by Appleton, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tan, M
Right arrow Articles by Appleton, R
Archives of Disease in Childhood 2005;90:57-59
© 2005 BMJ Publishing Group & Royal College of Paediatrics and Child Health


CURRENT TOPIC

Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy

M Tan, R Appleton

Correspondence to:
Correspondence to:
Dr R Appleton
The Roald Dahl EEG Unit, Department of Neurology, Royal Liverpool Children’s Hospital (Alder Hey), Eaton Road, Liverpool L12 2AP, UK; Richard.Appleton{at}RLCH-TR.NWEST.NHS.UK


ABSTRACT
Attention deficit hyperactivity disorder (ADHD) is characterised by inattention, impulsivity, and hyperactivity. The DSM-IV diagnosis of ADHD requires the presence of six of nine items or features that must have been present for at least six months, to have had an onset before 7 years of age, and to have resulted in significant distress or impairment.1 In the general population, the prevalence of ADHD is approximately 5%.2 There is a high co-morbidity of epilepsy and attentional and behavioural problems,3,4 including ADHD, and it has been estimated that at least 20% of patients with epilepsy may present with features of ADHD.5


Abbreviations: ADHD, attention deficit hyperactivity disorder; AED, antiepileptic activity; CAE, childhood onset absence epilepsy; EEG, electroencephalogram

Keywords: attention deficit; hyperactivity; epilepsy; methylphenidate




This article has been cited by other articles:


Home page
J Child NeurolHome page
J. G. M. Hendriksen and J. S. H. Vles
Neuropsychiatric Disorders in Males With Duchenne Muscular Dystrophy: Frequency Rate of Attention-Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder, and Obsessive--Compulsive Disorder
J Child Neurol, May 1, 2008; 23(5): 477 - 481.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
D. J. Nutt, K. Fone, P. Asherson, D. Bramble, P. Hill, K. Matthews, K. A. Morris, P. Santosh, E. Sonuga-Barke, E. Taylor, et al.
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology
J Psychopharmacol, January 1, 2007; 21(1): 10 - 41.
[Abstract] [PDF]


Home page
NeurologyHome page
A. P. Aldenkamp, A. Arzimanoglou, R. Reijs, and S. Van Mil
Optimizing therapy of seizures in children and adolescents with ADHD
Neurology, December 26, 2006; 67(12_suppl_4): S49 - S51.
[Abstract] [Full Text]

eLetters:

Read all eLetters

ADHD, psychostimulants and epilepsy
Somnath Banerjee
ADC Online, 10 Jan 2005 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health